ProAir® HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than ventolin® HFA

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 2, 2012, Pages 104-109

  McCabe, Jacquelyn Cruz ^a   Koppenhagen, Franciscus ^a   Blair, Julian ^b   Zeng, Xian Ming ^a  

^a Teva Branded Pharmaceutical Products RandD Inc   (United States)

^b Teva Pharmaceutical   (Ireland)

Author keywords

asthma; inhalation; metered dose inhalers; patient satisfaction; propellant

Indexed keywords

FLUORINATED HYDROCARBON; PROCATEROL; SALBUTAMOL;

ARTICLE; DRUG DELIVERY SYSTEM; FLOW RATE; HUMIDITY; METERED DOSE INHALER; PARTICLE SIZE; PLUME; ROOM TEMPERATURE;

ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; HUMANS; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; PARTICLE SIZE; TEMPERATURE; TIME FACTORS;

EID: 84859414017     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0891     Document Type: Article

References (20)

1. U.S. Department of Health and Human Services: Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. 8-28-0007. NHLBI Health Information Center, Bethesda, MD; pp. 1-440, 2010.
2. National Public Opinion Research Organization Abt, SRBI Inc.: Asthma Insight and Management Survey. Executive Summary. National Public Opinion Research Organization Abt, SRBI Inc., New York; pp. 1-114, 2010.
3. Ostrom N, Nathan R, Lanier B, Anolik R, Colice G, Marcus P, Schwartz J, Geller DE, and Blaiss MA: A comprehensive. survey of healthcare professionals and asthma patients offering insight on current treatment gaps and emerging device options. J Allergy Clin Immunol. 2009;125.
4. Rau JL: The inhalation of drugs: advantages and problems. Respir Care. 2005;50:367-382.
5. Global Initiative for Asthma: Global strategy for asthma management and prevention. Global Initiative for Asthma Web site, pp. ii-92, 2007.
6. Shikiar R, and Rentz AM: Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7:204-215.
7. Gabrio BJ, Stein SW, and Velasquez DJ: A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm. 1999;186:3-12.
8. Newman SP: Principles of metered-dose inhaler design. Respir Care. 2005;50:1177-1190.
9. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, and Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12.
10. Bell J, and Newman S: The rejuvenated pressurised metered dose inhaler. Exp Opin Drug Deliv. 2007;4:215-234.
11. Leach C: Effect of formulation parameters on hydrofluoroalkane- beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol. 1999;104:S250-S252.
12. Alexander DJ: Safety of propellants. J Aerosol Med. 1995;8: S29-S34.
13. GlaxoSmithKline: VENTOLIN HFA- (albuterol sulfate) Inhalation Aerosol. GlaxoSmithKline, Research Triangle Park, NC; 2009.
14. Teva Specialty Pharmaceuticals, Inc.: PROAIR HFA (Albuterol Sulfate) Inhalation Aerosol. Teva Specialty Pharmaceuticals LLC, Horsham, PA; 2008.
15. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, and White J: Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1-149.
16. Longest PW, and Hindle M: Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths. J Aerosol Med Pulmon Drug Deliv. 2009;22:271-283.
17. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, Guyatt G. American College of Chest Physicians, and American College of Asthma, Allergy, and Immunology: Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335-371.
18. Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, and Donnell D: Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol. 2000;106:1209-1226.
19. Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, and Colice GL: Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol. 1999;104:1215-1222.
20. Smyth H, Brace G, Barbour T, Gallion J, Grove J, and Hickey AJ: Spray pattern analysis for metered dose inhalers: effect of actuator design. Pharm Res. 2006;23:1591-1596